he Pancreatic cancer he The third leading cause of cancer death in the United StatesAccording to National Cancer Institute, and one of the deadliest. The five-year survival rate for pancreatic cancer is just 13%, and for those whose cancer has spread to other parts of the body, it drops to 3%.
In this context of the rush to find a solution,… Food and Drug Administration (FDA) Awarded in October to Revolutionary medicinesthe biotechnology company sponsoring the drug, An innovative new rapid review aims to bring promising medicines to patients faster than ever before.
This medicine is used to treat pancreatic cancer, along with other selected medicines under the heading “The Commissioner’s National Priority Voucher will test whether the development of innovative treatments can be accelerated Without compromising the accuracy of the agency’s reviews, according to experts.
Authoritarians don’t like this
The practice of professional and critical journalism is an essential pillar of democracy. This is why it bothers those who believe they are the bearers of the truth.
The US Food and Drug Administration said the program could shorten drug review from a year to less than a month, allowing companies that receive the agency’s approval to sell the drug sooner.
About The Author
